Loading asset research
Zenas BioPharma Inc. Common Stock
ZBIONasdaq · USD · StocksQuote as of · Exchange session not verified$31.15
+0.14%
Today
ZBIO
Loading 1D prices…
Market cap
$2B
Volume
421.7K
52w high
$44.6052w low
$13.50Company profile
Zenas BioPharma Inc. Common Stock
Zenas BioPharma, Inc., a clinical-stage biopharma company, engages in the development and commercialization of transformative immunology-based therapies. Its lead product candidate is obexelimab, a bifunctional monoclonal antibody designed to bind CD19 and Fc?RIIb for the treatment of various I&I diseases and various indications, including immunoglobulin G4-related disease, multiple sclerosis, and systemic lupus erythematosus. The company develops ZB002, an anti-TNFa monoclonal antibody; ZB004, a CTLA-4-Ig fusion protein designed to have an extended half-life versus; and ZB001, an anti-IGF-1R monoclonal antibody. The company was formerly known as Zenas BioPharma (Cayman) Limited and changed its name to Zenas BioPharma, Inc. in August 2023. The company was incorporated in 2019 and is headquartered in Waltham, Massachusetts.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
Display currency
USD
Location
Waltham, MA, United States
Employees
167
Fiscal year end
1231
CIK
1953926
Session & valuation
Open$31.48
Previous close$31.10
Day high$32.31
Day low$31.12
30-day avg. volume644.8K
Outstanding shares65.2M
Diluted EPS-$8.44
Latest annual period
P/E (trailing)-3.69
P/E (forward)-6.68
Price / book7.98
Beta—
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2834
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| GENBGenerate Biomedicines Inc. Common Stock | $2B | $31.9M | -636.99% | -$2.18 | +2.21% | Buy |
| AGIOAgios Pharmaceuticals Inc. Common Stock | $2B | $54M | -764.42% | -$7.12 | -0.18% | Buy |
| URGNUroGen Pharma Ltd. Ordinary Shares | $2.1B | $109.8M | -139.81% | -$3.19 | +0.19% | Buy |
| CMPSCOMPASS Pathways Plc American Depository Shares | $2B | $0.00 | — | -$3.08 | +0.98% | Buy |
| RAPPRapport Therapeutics Inc. Common Stock | $2.1B | $0.00 | — | -$2.86 | +0.69% | Buy |